The  Thirteenth Meeting of the Parties  decided in  Dec. XIII/8:      To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its Technical Options Committees;   To authorize the levels of production and consumption necessary to satisfy essential uses of CFCs for metered-dose inhalers (MDIs) for asthma and chronic obstructive pulmonary disease and CFC-113 for torpedo maintenance as specified in Annex I to the report of the 13th Meeting of the Parties